MedTrace Logo

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

NCT02256670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-02-06

No results posted yet for this study

Summary

Pilot study to assess feasibility and patient acceptance of a text message cell phone application for patients with stage I-III, hormone receptor positive breast cancer who start adjuvant endocrine therapy.

Conditions

Interventions

BEHAVIORAL

Text Message Application

Two-way text messaging application addressing adherence with adjuvant endocrine therapy

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Sarah Mougalian, MD · Yale University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-01-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02256670 on ClinicalTrials.gov